Human papillomavirus vaccine

Human papillomavirus vaccine

M715/0589 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 62.0MB

Downloadable file size: 2.5MB

Price image Pricing

Please login to use the price calculator


Credit: DR P. MARAZZI/SCIENCE PHOTO LIBRARY

Caption: Human papillomavirus vaccine. This syringe contains Gardasil, the world's first commercially available vaccine against diseases caused by the human papillomavirus (HPV). It works by using inactive virus particles, which trigger an immune response without causing any illness. Once the immune system has been exposed to the vaccine, it will be better prepared to prevent infection by the active virus. It is hoped that this vaccine will drastically reduce the number of HPV-related cancers, such as cervical cancer. After undergoing extensive research and clinical trials, this vaccine was approved for use on 8th June 2006.

Release details: Model release not required. Property release not required.

Keywords: 2006, 21st century, approved, brand, cervical cancer, commercial, commercially available, dose, drug, gardasil, healthcare, hpv, human papilloma virus, human papillomavirus, immunisation, inactive virus, injection, inoculation, logo, medical, medicine, needle, particle, particles, pharmaceutical, pharmacological, pharmacology, syringe, treatment, treatments, vaccination, vaccine, viral

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.